Company Amoy Diagnostics Co., Ltd.

Equities

300685

CNE1000034D3

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Amoy Diagnostics Co., Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
18.44 ^CNY	+0.05%		-7.10%	-16.11%

Apr. 22	Amoy Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 15	Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Amoy Diagnostics Co Ltd is a pharmaceutical company engaged in research, development, production and sales of molecular diagnostic products. The Company provides testing reagents and testing services for tumor diagnosis. The Companyâs testing reagent products include ADx-ARMS product line for tumor tissue specimen detection, Super-ARMS product line for liquid biopsy, the NGS product line and the FISH product line. The products are used for the detection of non-small cell lung cancer, colorectal cancer, thyroid cancer, melanoma and other malignant tumors. The Company also provides data software to capture and analyze gene sequencing data. The Company provides testing services through its own medical testing institutions, including lung cancer testing, colorectal cancer testing and breast cancer testing.

Number of employees: 1,119

CNY in Million	2022	Weight	2023	Weight	Delta
Detection Reagents 82.4 %	611	72.6 %	860	82.4 %	+40.64%
Drug Clinical Research Services 8.5 %	86	10.2 %	89	8.5 %	+3.10%
Testing Services 8.1 %	135	16.0 %	85	8.1 %	-37.09%
Other 1.0 %	10	1.2 %	10	1.0 %	+2.42%

CNY in Million	2022	Weight	2023	Weight	Delta
China 81.2 %	697	82.8 %	847	81.2 %	+21.54%
Overseas 18.8 %	145	17.2 %	196	18.8 %	+35.27%

Managers	Title	Age	Since
Jie Min Luo CEO	Chief Executive Officer	41	11-12-31
Li Mou Zheng FOU	Founder	71	08-02-20
Ying Chen DFI	Director of Finance/CFO	54	15-03-31
Hong Yu Wang CHM	Chairman	40	10-05-31
Frank Zheng BRD	Director/Board Member	34	16-12-31
Fei Luo BRD	Director/Board Member	46	09-07-31
Shou Gan Yang IRC	Investor Relations Contact	-	-
Hui Bin Zheng PRN	Corporate Officer/Principal	62	11-06-30

Members of the board	Title	Age	Since
Li Mou Zheng FOU	Founder	71	08-02-20
Fei Luo BRD	Director/Board Member	46	09-07-31
Xin Huang BRD	Director/Board Member	76	15-06-17
Hui Bin Zheng PRN	Corporate Officer/Principal	62	11-06-30
Ning Cai BRD	Director/Board Member	47	17-03-31
Hong Yu Wang CHM	Chairman	40	10-05-31
Frank Zheng BRD	Director/Board Member	34	16-12-31
En Hua Huang BRD	Director/Board Member	69	21-09-29
Wen Jin Su BRD	Director/Board Member	68	21-09-29
Qi Du BRD	Director/Board Member	79	21-08-12

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	402,929,809	257,034,570 ( 63.79 %)	4,389,500 ( 1.089 %)	63.79 %

Name	Equities	%	Valuation
Li Mou Zheng 22.06 %	87,701,616	22.06 %	265 M ¥
Xiamen Yixiang Investment Partnership LP 5.038 %	20,026,900	5.038 %	61 M ¥
Xiao Li Qiu 4.997 %	19,866,146	4.997 %	60 M ¥
Harvest Fund Management Co., Ltd. 4.494 %	17,866,370	4.494 %	54 M ¥
Zuo Hua Lin 2.174 %	8,642,433	2.174 %	26 M ¥
Xiamen Haicang Rundingsheng Investment LP 1.827 %	7,264,926	1.827 %	22 M ¥
UBS GROUP AG 1.569 %	6,237,438	1.569 %	19 M ¥
ICBC Credit Suisse Asset Management Co., Ltd. 1.239 %	4,924,430	1.239 %	15 M ¥
AMOY DIAGNOSTICS CO., LTD. 0.8882 %	3,531,226	0.8882 %	11 M ¥
Da Cheng Fund Management Co., Ltd. 0.8302 %	3,300,560	0.8302 %	10 M ¥

Name	Equities	%	Valuation
AMOY DIAGNOSTICS CO., LTD. 0.89%	3,531,226	0.89%	10,669,493 $

Amoy Diagnostics Co., Ltd.

39 Dingshan Road Haicang District

361027, Xiamen

http://www.amoydx.com

address Amoy Diagnostics Co., Ltd.(300685)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.44 CNY

Average target price

28.6 CNY

Spread / Average Target

+55.08%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
AMOY DIAGNOSTICS CO., LTD.	-16.11%	1B
BIOMÉRIEUX	-6.41%	12.2B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-4.07%	8.22B
DIASORIN S.P.A.	+5.77%	5.72B
LANTHEUS HOLDINGS, INC.	+27.40%	5.42B
10X GENOMICS, INC.	-60.10%	2.7B
ANDON HEALTH CO., LTD.	+8.04%	2.63B
VITROLIFE AB	-6.47%	2.38B
MYRIAD GENETICS, INC.	+22.60%	2.1B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.15%	1.81B

Diagnostic & Testing Substances